Oxidative stress: Introduction

被引：8

作者：

Haffner, SM ^{[1
]}

机构：

[1] Univ Texas, Hlth Sci Ctr, San Antonio, TX 78284 USA

来源：

METABOLISM-CLINICAL AND EXPERIMENTAL | 2000年 / 49卷 / 02期

关键词：

D O I：

10.1016/S0026-0495(00)80076-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1 / 2

页数：2

共 10 条

[1] LIPOPROTEIN OXIDATION AND LIPOPROTEIN-INDUCED CELL INJURY IN DIABETES [J].

CHISOLM, GM ;

IRWIN, KC ;

PENN, MS .

DIABETES, 1992, 41 :61-66

[2] Diabetes and decline in heart disease mortality in US adults [J].

Gu, K ;

Cowie, CC ;

Harris, MI .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (14) :1291-1297

[3] PLASMA OXIDIZABILITY IN SUBJECTS WITH NORMAL GLUCOSE-TOLERANCE, IMPAIRED GLUCOSE-TOLERANCE, AND NIDDM [J].

HAFFNER, SM ;

AGIL, A ;

MYKKANEN, L ;

STERN, MP ;

JIALAL, I .

DIABETES CARE, 1995, 18 (05) :646-653

[4] Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction [J].

Haffner, SM ;

Lehto, S ;

Rönnemaa, T ;

Pyörälä, K ;

Laakso, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (04) :229-234

[5] Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease - A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) [J].

Pyorala, K ;

Pedersen, TR ;

Kjekshus, J ;

Faergeman, O ;

Olsson, AG ;

Thorgeirsson, G .

DIABETES CARE, 1997, 20 (04) :614-620

[6]

Stearne MR, 1998, BRIT MED J, V317, P713

[7]

Stearne MR, 1998, BMJ-BRIT MED J, V317, P703

[8]

STEINBERG D, 1989, NEW ENGL J MED, V320, P915

[9] Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) [J].

Turner, RC ;

Holman, RR ;

Stratton, IM ;

Cull, CA ;

Matthews, DR ;

Manley, SE ;

Frighi, V ;

Wright, D ;

Neil, A ;

Kohner, E ;

McElroy, H ;

Fox, C ;

Hadden, D .

LANCET, 1998, 352 (9131) :854-865

[10] Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [J].

Turner, RC ;

Holman, RR ;

Cull, CA ;

Stratton, IM ;

Matthews, DR ;

Frighi, V ;

Manley, SE ;

Neil, A ;

McElroy, K ;

Wright, D ;

Kohner, E ;

Fox, C ;

Hadden, D ;

Mehta, Z ;

Smith, A ;

Nugent, Z ;

Peto, R ;

Adlel, AI ;

Mann, JI ;

Bassett, PA ;

Oakes, SF ;

Dornan, TL ;

Aldington, S ;

Lipinski, H ;

Collum, R ;

Harrison, K ;

MacIntyre, C ;

Skinner, S ;

Mortemore, A ;

Nelson, D ;

Cockley, S ;

Levien, S ;

Bodsworth, L ;

Willox, R ;

Biggs, T ;

Dove, S ;

Beattie, E ;

Gradwell, M ;

Staples, S ;

Lam, R ;

Taylor, F ;

Leung, L ;

Carter, RD ;

Brownlee, SM ;

Fisher, KE ;

Islam, K ;

Jelfs, R ;

Williams, PA ;

Williams, FA ;

Sutton, PJ .

LANCET, 1998, 352 (9131) :837-853

← 1 →